• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蛋白酶体激活剂PA28和PA26调控糖尿病肾病和视网膜病变中微血管损伤的发展。

Proteasome Activators, PA28 and PA28, Govern Development of Microvascular Injury in Diabetic Nephropathy and Retinopathy.

作者信息

Yadranji Aghdam Saeed, Mahmoudpour Ali

机构信息

Reynolds Institute on Aging, Room No. 4151, 629 Jack Stephens Drive, Little Rock, AR 72205, USA; Department of Geriatrics, University of Arkansas for Medical Sciences, Little Rock, AR, USA.

Norgen Biotek Corp., 3430 Schmon Parkway, Thorold, ON, Canada L2V 4Y6.

出版信息

Int J Nephrol. 2016;2016:3846573. doi: 10.1155/2016/3846573. Epub 2016 Oct 18.

DOI:10.1155/2016/3846573
PMID:27830089
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5088333/
Abstract

Diabetic nephropathy (DN) and diabetic retinopathy (DR) are major complications of type 1 and type 2 diabetes. DN and DR are mainly caused by injury to the perivascular supporting cells, the mesangial cells within the glomerulus, and the pericytes in the retina. The genes and molecular mechanisms predisposing retinal and glomerular pericytes to diabetic injury are poorly characterized. In this study, the genetic deletion of proteasome activator genes, PA28 and PA28 genes, protected the diabetic mice in the experimental STZ-induced diabetes model against renal injury and retinal microvascular injury and prolonged their survival compared with wild type STZ diabetic mice. The improved wellbeing and reduced renal damage was associated with diminished expression of Osteopontin (OPN) and Monocyte Chemoattractant Protein-1 (MCP-1) in the glomeruli of STZ-injected PA28/PA28 double knockout (Pa28DKO) mice and also in cultured mesangial cells and retinal pericytes isolated from Pa28DKO mice that were grown in high glucose. The mesangial PA28-mediated expression of OPN under high glucose conditions was suppressed by peptides capable of inhibiting the binding of PA28 to the 20S proteasome. Collectively, our findings demonstrate that diabetic hyperglycemia promotes PA28-mediated alteration of proteasome activity in vulnerable perivascular cells resulting in microvascular injury and development of DN and DR.

摘要

糖尿病肾病(DN)和糖尿病视网膜病变(DR)是1型和2型糖尿病的主要并发症。DN和DR主要是由血管周围支持细胞、肾小球内的系膜细胞以及视网膜中的周细胞损伤引起的。导致视网膜和肾小球周细胞易受糖尿病损伤的基因和分子机制目前尚不清楚。在本研究中,蛋白酶体激活基因PA28α和PA28β的基因缺失,在实验性链脲佐菌素诱导的糖尿病模型中保护糖尿病小鼠免受肾损伤和视网膜微血管损伤,并与野生型链脲佐菌素糖尿病小鼠相比延长了它们的生存期。与注射链脲佐菌素的PA28α/PA28β双敲除(Pa28DKO)小鼠肾小球中骨桥蛋白(OPN)和单核细胞趋化蛋白-1(MCP-1)表达降低相关,并且在从高糖培养的Pa28DKO小鼠分离的培养系膜细胞和视网膜周细胞中也降低。在高糖条件下,能够抑制PA28与20S蛋白酶体结合的肽抑制了系膜细胞中PA28介导的OPN表达。总的来说,我们的研究结果表明,糖尿病高血糖促进PA28介导的易损血管周围细胞中蛋白酶体活性改变,导致微血管损伤以及DN和DR的发展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c85/5088333/c40baac62770/IJN2016-3846573.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c85/5088333/1f1e7b1c91c7/IJN2016-3846573.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c85/5088333/35a6d5a66dc0/IJN2016-3846573.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c85/5088333/53e59be718f6/IJN2016-3846573.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c85/5088333/88e30ade4f8a/IJN2016-3846573.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c85/5088333/47c118237df3/IJN2016-3846573.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c85/5088333/c40baac62770/IJN2016-3846573.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c85/5088333/1f1e7b1c91c7/IJN2016-3846573.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c85/5088333/35a6d5a66dc0/IJN2016-3846573.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c85/5088333/53e59be718f6/IJN2016-3846573.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c85/5088333/88e30ade4f8a/IJN2016-3846573.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c85/5088333/47c118237df3/IJN2016-3846573.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c85/5088333/c40baac62770/IJN2016-3846573.006.jpg

相似文献

1
Proteasome Activators, PA28 and PA28, Govern Development of Microvascular Injury in Diabetic Nephropathy and Retinopathy.蛋白酶体激活剂PA28和PA26调控糖尿病肾病和视网膜病变中微血管损伤的发展。
Int J Nephrol. 2016;2016:3846573. doi: 10.1155/2016/3846573. Epub 2016 Oct 18.
2
Inhibition of the Proteasome Regulator PA28 Aggravates Oxidized Protein Overload in the Diabetic Rat Brain.蛋白酶体调节剂 PA28 的抑制加剧了糖尿病大鼠大脑中的氧化蛋白过载。
Cell Mol Neurobiol. 2023 Aug;43(6):2857-2869. doi: 10.1007/s10571-023-01322-y. Epub 2023 Jan 30.
3
Nitric oxide differentially affects proteasome activator 28 after arterial injury in type 1 and type 2 diabetic rats.一氧化氮对1型和2型糖尿病大鼠动脉损伤后蛋白酶体激活因子28有不同影响。
J Surg Res. 2016 May 15;202(2):413-21. doi: 10.1016/j.jss.2016.01.030. Epub 2016 Jan 30.
4
Lipotoxicity dysregulates the immunoproteasome in podocytes and kidneys in type 2 diabetes.脂毒性失调导致 2 型糖尿病中肾小球足细胞和肾脏的免疫蛋白酶体紊乱。
Am J Physiol Renal Physiol. 2021 Apr 1;320(4):F548-F558. doi: 10.1152/ajprenal.00509.2020. Epub 2021 Feb 15.
5
High glucose and diabetes modulate cellular proteasome function: Implications in the pathogenesis of diabetes complications.高血糖和糖尿病调节细胞蛋白酶体功能:在糖尿病并发症发病机制中的意义。
Biochem Biophys Res Commun. 2013 Mar 8;432(2):339-44. doi: 10.1016/j.bbrc.2013.01.101. Epub 2013 Feb 4.
6
p27(Kip1) Knockout mice are protected from diabetic nephropathy: evidence for p27(Kip1) haplotype insufficiency.p27(Kip1)基因敲除小鼠可预防糖尿病肾病:p27(Kip1)单倍型不足的证据。
Kidney Int. 2005 Oct;68(4):1583-9. doi: 10.1111/j.1523-1755.2005.00570.x.
7
Tubular overexpression of Gremlin in transgenic mice aggravates renal damage in diabetic nephropathy.在转基因小鼠中,Gremlin在肾小管中的过表达会加重糖尿病肾病中的肾损伤。
Am J Physiol Renal Physiol. 2015 Sep 15;309(6):F559-68. doi: 10.1152/ajprenal.00023.2015. Epub 2015 Jul 8.
8
PA28 modulates antigen processing and viral replication during coxsackievirus B3 infection.PA28在柯萨奇病毒B3感染期间调节抗原加工和病毒复制。
PLoS One. 2017 Mar 9;12(3):e0173259. doi: 10.1371/journal.pone.0173259. eCollection 2017.
9
The anti-inflammation effect of Moutan Cortex on advanced glycation end products-induced rat mesangial cells dysfunction and High-glucose-fat diet and streptozotocin-induced diabetic nephropathy rats.牡丹皮对糖基化终产物诱导的大鼠肾小球系膜细胞功能障碍及高糖高脂饮食联合链脲佐菌素诱导的糖尿病肾病大鼠的抗炎作用。
J Ethnopharmacol. 2014;151(1):591-600. doi: 10.1016/j.jep.2013.11.015. Epub 2013 Nov 21.
10
The ubiquitin-proteasome system and microvascular complications of diabetes.泛素-蛋白酶体系统与糖尿病微血管并发症
J Ophthalmic Vis Res. 2013 Jul;8(3):244-56.

引用本文的文献

1
RBBP6-Mediated ERRα Degradation Contributes to Mitochondrial Injury in Renal Tubular Cells in Diabetic Kidney Disease.RBBP6介导的ERRα降解促成糖尿病肾病肾小管细胞的线粒体损伤。
Adv Sci (Weinh). 2024 Dec;11(46):e2405153. doi: 10.1002/advs.202405153. Epub 2024 Oct 23.
2
CCDC92 promotes podocyte injury by regulating PA28α/ABCA1/cholesterol efflux axis in type 2 diabetic mice.CCDC92 通过调控 PA28α/ABCA1/胆固醇外排轴促进 2 型糖尿病小鼠足细胞损伤。
Acta Pharmacol Sin. 2024 May;45(5):1019-1031. doi: 10.1038/s41401-023-01213-4. Epub 2024 Jan 16.
3
Modeling SILAC Data to Assess Protein Turnover in a Cellular Model of Diabetic Nephropathy.

本文引用的文献

1
The proteasome inhibitor, MG132, attenuates diabetic nephropathy by inhibiting SnoN degradation in vivo and in vitro.蛋白酶体抑制剂MG132通过在体内和体外抑制SnoN降解来减轻糖尿病肾病。
Biomed Res Int. 2014;2014:684765. doi: 10.1155/2014/684765. Epub 2014 Jun 9.
2
Osteopontin is a strong predictor of incipient diabetic nephropathy, cardiovascular disease, and all-cause mortality in patients with type 1 diabetes.骨桥蛋白是 1 型糖尿病患者发生早期糖尿病肾病、心血管疾病和全因死亡率的强有力预测指标。
Diabetes Care. 2014 Sep;37(9):2593-600. doi: 10.2337/dc14-0065. Epub 2014 Jun 26.
3
Microinflammation in the pathogenesis of diabetic nephropathy.
用 SILAC 数据模型评估糖尿病肾病细胞模型中的蛋白质周转率。
Int J Mol Sci. 2023 Feb 1;24(3):2811. doi: 10.3390/ijms24032811.
4
Molecular Mechanisms Underlying Pathological and Therapeutic Roles of Pericytes in Atherosclerosis.周细胞在动脉粥样硬化中的病理和治疗作用的分子机制。
Int J Mol Sci. 2022 Oct 1;23(19):11663. doi: 10.3390/ijms231911663.
5
Ubiquitin-proteasome system in diabetic retinopathy.糖尿病性视网膜病变中的泛素-蛋白酶体系统。
PeerJ. 2022 Jul 19;10:e13715. doi: 10.7717/peerj.13715. eCollection 2022.
6
RNA-Seq analysis reveals critical transcriptome changes caused by sodium butyrate in DN mouse models.RNA-Seq 分析揭示了丁酸钠在 DN 小鼠模型中引起的关键转录组变化。
Biosci Rep. 2021 Apr 30;41(4). doi: 10.1042/BSR20203005.
微炎症在糖尿病肾病发病机制中的作用
J Diabetes Investig. 2013 Mar 18;4(2):142-9. doi: 10.1111/jdi.12050.
4
Dissecting a role of a charge and conformation of Tat2 peptide in allosteric regulation of 20S proteasome.剖析Tat2肽的电荷和构象在20S蛋白酶体变构调节中的作用。
J Pept Sci. 2014 Aug;20(8):649-56. doi: 10.1002/psc.2642. Epub 2014 May 13.
5
Diabetic kidney disease: a clinical update from Kidney Disease: Improving Global Outcomes.糖尿病肾病:来自改善全球肾脏病预后组织(KDIGO)的临床最新进展
Kidney Int. 2015 Jan;87(1):20-30. doi: 10.1038/ki.2014.128. Epub 2014 Apr 30.
6
The proteasome and the degradation of oxidized proteins: part III-Redox regulation of the proteasomal system.蛋白酶体与氧化蛋白的降解:第三部分——蛋白酶体系统的氧化还原调节
Redox Biol. 2014 Jan 14;2:388-94. doi: 10.1016/j.redox.2013.12.029. eCollection 2014.
7
MG132 ameliorates kidney lesions by inhibiting the degradation of Smad7 in streptozotocin-induced diabetic nephropathy.MG132 通过抑制链脲佐菌素诱导的糖尿病肾病中 Smad7 的降解来改善肾脏病变。
J Diabetes Res. 2014;2014:918396. doi: 10.1155/2014/918396. Epub 2014 Jan 5.
8
The ubiquitin-proteasome system and microvascular complications of diabetes.泛素-蛋白酶体系统与糖尿病微血管并发症
J Ophthalmic Vis Res. 2013 Jul;8(3):244-56.
9
High glucose and diabetes modulate cellular proteasome function: Implications in the pathogenesis of diabetes complications.高血糖和糖尿病调节细胞蛋白酶体功能:在糖尿病并发症发病机制中的意义。
Biochem Biophys Res Commun. 2013 Mar 8;432(2):339-44. doi: 10.1016/j.bbrc.2013.01.101. Epub 2013 Feb 4.
10
Critical role of TXNIP in oxidative stress, DNA damage and retinal pericyte apoptosis under high glucose: implications for diabetic retinopathy.TXNIP 在高糖环境下的氧化应激、DNA 损伤和视网膜周细胞凋亡中的关键作用:对糖尿病视网膜病变的影响。
Exp Cell Res. 2013 Apr 15;319(7):1001-12. doi: 10.1016/j.yexcr.2013.01.012. Epub 2013 Jan 24.